| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $3.0M | -12.2% |
| SG&A Expense | $3.9M | +5.9% |
| Operating Income | -$7.0M | +3.0% |
| Net Income | -$6.8M | +11.3% |
| EPS (Basic) | -$15.25 | +86.6% |
| EPS (Diluted) | -$15.25 | +86.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.2M | +20.1% |
| Current Assets | $5.5M | +11.5% |
| Total Assets | $7.1M | +6.9% |
| Current Liabilities | $1.1M | +38.1% |
| Total Liabilities | $1.1M | +23.3% |
| Stockholders' Equity | $6.0M | +4.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.1M | +22.6% |
| Capital Expenditures | $174K | -43.4% |
| Investing Cash Flow | -$174K | +43.4% |
| Financing Cash Flow | $7.1M | -30.6% |
| Free Cash Flow | -$6.2M | +23.4% |